See also this year's filing and all EDGAR filings for this company.
PDF Report 0001673772_2023_RAPT_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001673772, RAPT Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 252,694,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,539,000 |
| 3 | remainder_Assets | 10,976,000 |
| 4 | LiabilitiesCurrent | 14,224,000 |
| 5 | LiabilitiesNoncurrent | 6,819,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 20,240,000 |
| 9 | ResearchAndDevelopmentExpense | 67,082,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 1,527,000 |
| 12 | remainder_NetIncome | 1,957,000 |
| 13 | remainder_ComprehensiveNetIncome | 180,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 266,209,000 |
| 1 | Liabilities | 21,043,000 |
| 2 | Expenses | 87,322,000 |
| 3 | Revenues | 1,527,000 |
| 4 | StockholdersEquity | 245,166,000 |
| 5 | NetIncome | -83,838,000 |
| 6 | ComprehensiveNetIncome | -83,748,000 |
| 7 | BaseVar | 189,119,000 |
| 8 | EconomicCapitalRatio | 2.35 |